Skip to main content
logo
Swedish Orphan Biovitrum AB (publ) (BIOVF)
OTCMKTS · Delayed Price · Currency is USD
33.30
+3.25 (10.83%)
At close: Oct 6, 2025

Revenue by Product

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192014 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
Haematology
13.37B
Log In
Log In
Log In
Log In
Upgrade
Haematology Growth
23.44%
Log In
Log In
Log In
Log In
Upgrade
Immunology
7.64B
Log In
Log In
Log In
Log In
Upgrade
Immunology Growth
14.31%
Log In
Log In
Log In
Log In
Upgrade
Specialty Care
1.12B
Log In
Log In
Log In
Log In
Upgrade
Specialty Care Growth
-12.58%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192014 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
United States
8.15B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
10.65%
Log In
Log In
Log In
Log In
Upgrade
Europe
7.85B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
119.00%
Log In
Log In
Log In
Log In
Upgrade
Global
2.72B
Log In
Log In
Log In
Log In
Upgrade
Global Growth
90.47%
Log In
Log In
Log In
Log In
Upgrade
Rest of the World
2.65B
Log In
Log In
Log In
Log In
Upgrade
Rest of the World Growth
8.82%
Log In
Log In
Log In
Log In
Upgrade
Sweden
660.00M
Log In
Log In
Log In
Log In
Upgrade
Sweden Growth
-1.05%
Log In
Log In
Log In
Log In
Upgrade
North America
93.00M
Log In
Log In
Log In
Log In
Upgrade
North America Growth
20.78%
Log In
Log In
Log In
Log In
Upgrade
France
-
Log In
Log In
Log In
Log In
Upgrade
France Growth
-
Log In
Log In
Log In
Log In
Upgrade
Germany
-
Log In
Log In
Log In
Log In
Upgrade
Germany Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other Countries Europe
-
Log In
Log In
Log In
Log In
Upgrade
Italy
-
Log In
Log In
Log In
Log In
Upgrade